Almac Group to invest £54m and create 348 new jobs
Investment, supported by Invest Northern Ireland, relates to two operating business units, Pharma Services and Clinical Services
The Almac Group is investing more than £54m and creating 348 high quality jobs over the next five years. The investment, supported by Invest Northern Ireland, relates to two of the Group’s operating business units: Pharma Services and Clinical Services.
Almac Pharma Services provides contract development and manufacturing services to the world’s leading pharmaceutical and biotech companies. As well as recruiting 141 new staff over the next five years, the company will invest in new technologies and equipment to take advantage of the growing demand for outsourced development services.
Almac Clinical Services provides clinical packaging, labelling, logistics and clinical supply chain management services to the pharmaceutical industry. It is investing in cold chain storage and distribution facilities and enhanced information systems to capitalise on the demand from clients for closer partnering opportunities. The unit is creating 181 new jobs over the next five years.
The investments will also create a further 26 new jobs within the Group.
Announcing the investment, Enterprise, Trade and Investment Minister Arlene Foster said: 'Almac is one of Northern Ireland’s most successful indigenous companies and a globally respected brand. This significant investment will enable Almac to expand the range of services it can offer, allowing it to respond to key trends within the pharmaceutical industry and enhance its market-leading position.'
Invest NI has offered Almac Group £5.5m of support towards its investment.
Alan Armstrong, Chairman and CEO of the Almac Group, said: 'We are fortunate to employ an excellent highly-skilled workforce at our Craigavon headquarters which has played a major role in our global growth. It’s fantastic that demand for our services has resulted in the creation of so many new jobs as we embark on further expansion over the next five years.'
